Cargando…
Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice
Tau, the main component of the neurofibrillary tangles (NFTs), is an attractive target for immunotherapy in Alzheimer’s disease (AD) and other tauopathies. MC1/Alz50 are currently the only antibodies targeting a disease-specific conformational modification of tau. Passive immunization experiments us...
Autores principales: | Vitale, Francesca, Giliberto, Luca, Ruiz, Santiago, Steslow, Kristen, Marambaud, Philippe, d’Abramo, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103963/ https://www.ncbi.nlm.nih.gov/pubmed/30134961 http://dx.doi.org/10.1186/s40478-018-0585-2 |
Ejemplares similares
-
Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models
por: Vitale, Francesca, et al.
Publicado: (2020) -
Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
por: d’Abramo, Cristina, et al.
Publicado: (2015) -
Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F, et al.
Publicado: (2017) -
Gait Ignition Failure in JNPL3 Human Tau-mutant Mice
por: Jang, HoChung, et al.
Publicado: (2019) -
Correction: Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F., et al.
Publicado: (2018)